World's Best Scientists 2026 revealed!
Thomas M. Habermann

Thomas M. Habermann

D-Index & Metrics

Medicine

D-Index
109
Citations
50385
World Ranking
5723
National Ranking
3076

Overview

Thomas M. Habermann is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on the field of medicine, with significant contributions in pathology and forensic medicine, oncology, genetics, neurology, and pulmonary and respiratory medicine.

Their publication record spans several key areas within these fields, including lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, CNS lymphoma diagnosis and treatment, viral-associated cancers and disorders, CAR-T cell therapy research, lung cancer treatments and mutations, and acute lymphoblastic leukemia research.

Frequent coauthors in their research include:

  • James R. Cerhan
  • Grzegorz S. Nowakowski
  • Matthew J. Maurer
  • Thomas E. Witzig
  • Stephen M. Ansell

Thomas M. Habermann has published extensively in well-known scientific venues, including:

  • Blood
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Hematological Oncology
  • Blood Cancer Journal

Selected recent papers authored or coauthored by Thomas M. Habermann include:

  • "NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021," 2021, Journal of the National Comprehensive Cancer Network
  • "Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement," 2020, American Journal of Transplantation
  • "Epidemiology of marginal zone lymphoma," 2021, Annals of Lymphoma
  • "Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412," 2021, Journal of Clinical Oncology
  • "NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023," 2023, Journal of the National Comprehensive Cancer Network

Best Publications

  • Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Bjoern Chapuy;Chip Stewart;Andrew J Dunford;Jaegil Kim

  • Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study.

    Colin P. West;Mashele M. Huschka;Paul J. Novotny;Jeff A. Sloan

  • Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

    Thomas M. Habermann;Edie A. Weller;Vicki A. Morrison;Randy D. Gascoyne

  • Association of Resident Fatigue and Distress With Perceived Medical Errors

    C.P. West;A.D. Tan;T.M. Habermann;J.A. Sloan

  • Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang

  • Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

    Jens G. Lohr;Petar Stojanov;Petar Stojanov;Michael S. Lawrence;Daniel Auclair

  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

    Kenneth R. Carson;Andrew M. Evens;Elizabeth A. Richey;Thomas M. Habermann

  • The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

    Kerry J. Savage;Stefano Monti;Jeffery L. Kutok;Giorgio Cattoretti

  • The well-being of physicians

    Tait D Shanafelt;Jeff A Sloan;Thomas M Habermann

  • Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

    Stefano Monti;Kerry J. Savage;Jeffery L. Kutok;Friedrich Feuerhake

  • Epstein-barr virus-induced posttransplant lymphoproliferative disorders

    Carlos V. Paya;John J. Fung;Michael A. Nalesnik;Elliott Kieff

  • Relationship between increased personal well-being and enhanced empathy among

    Tait D. Shanafelt;Colin West;Xinghua Zhao;Paul Novotny

  • Pretransplantation assessment of the risk of lymphoproliferative disorder

    Randall C. Walker;William F. Marshall;John G. Strickler;Russell H. Wiesner

  • Relationship between increased personal well-being and enhanced empathy among internal medicine residents

    Tait D. Shanafelt;Colin West;Xinghua Zhao;Paul Novotny

  • ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

    Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow

  • Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

    Peter H. Wiernik;Izidore S. Lossos;Joseph M. Tuscano;Glen Justice

  • Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

    Wei Ding;Betsy R. LaPlant;Timothy G. Call;Sameer A. Parikh

  • Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

    Sandra J. Horning;Edie Weller;Kyung Mann Kim;John D. Earle

  • Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.

    Stephen M. Ansell;Sara A. Hurvitz;Patricia A. Koenig;Betsy R. LaPlant

  • Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

    Grzegorz S Nowakowski;Betsy LaPlant;William R Macon;Craig B Reeder

Frequent Co-Authors

Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
James R. Cerhan
James R. Cerhan Mayo Clinic
David J. Inwards
David J. Inwards Mayo Clinic
Susan L. Slager
Susan L. Slager Mayo Clinic
Anne J. Novak
Anne J. Novak Mayo Clinic
Ahmet Dogan
Ahmet Dogan Memorial Sloan Kettering Cancer Center
Paul J. Kurtin
Paul J. Kurtin Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a wide range of careers in healthcare—many of which can be pursued through flexible online programs. For students interested in pharmacy, there are several online pharmacy schools that make it easier to advance your qualifications while working or managing other responsibilities.

Data and digital skills are increasingly important in healthcare institutions. An online bachelor's in health information management can prepare you for roles in managing patient records, data analysis, and health informatics—key areas as the industry moves toward greater electronic health adoption.

For those seeking quick entry to the medical field, consider the average cost of medical billing and coding program options. These programs allow you to gain in-demand administrative and technical expertise in months rather than years.

Nursing remains a cornerstone of medical care. If you are looking for career advancement in this field, explore the cheapest online np programs to become a Nurse Practitioner—a highly respected and increasingly vital profession within healthcare.

Best Scientists Citing Thomas M. Habermann

Trending Scientists